DE60024588T2 - Substituierte porphyrine und deren therapeutische verwendungen - Google Patents

Substituierte porphyrine und deren therapeutische verwendungen Download PDF

Info

Publication number
DE60024588T2
DE60024588T2 DE60024588T DE60024588T DE60024588T2 DE 60024588 T2 DE60024588 T2 DE 60024588T2 DE 60024588 T DE60024588 T DE 60024588T DE 60024588 T DE60024588 T DE 60024588T DE 60024588 T2 DE60024588 T2 DE 60024588T2
Authority
DE
Germany
Prior art keywords
same
manganese
mmol
porphyrin
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60024588T
Other languages
German (de)
English (en)
Other versions
DE60024588D1 (de
Inventor
James D. Crapo
Brian J. Day
Michael P. Trova
Polivini Jolicia F. Gauuan
Douglas B. Kitchen
Irwin Fridovich
Ines Batinic-Haberle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Jewish Health
Aeolus Sciences Inc
Duke University
Original Assignee
Aeolus Sciences Inc
National Jewish Medical and Research Center
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeolus Sciences Inc, National Jewish Medical and Research Center, Duke University filed Critical Aeolus Sciences Inc
Application granted granted Critical
Publication of DE60024588D1 publication Critical patent/DE60024588D1/de
Publication of DE60024588T2 publication Critical patent/DE60024588T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60024588T 1999-01-25 2000-01-25 Substituierte porphyrine und deren therapeutische verwendungen Expired - Lifetime DE60024588T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11701099P 1999-01-25 1999-01-25
US117010P 1999-01-25
PCT/US2000/002062 WO2000043395A1 (en) 1999-01-25 2000-01-25 Substituted porphyrins

Publications (2)

Publication Number Publication Date
DE60024588D1 DE60024588D1 (de) 2006-01-12
DE60024588T2 true DE60024588T2 (de) 2006-08-17

Family

ID=22370524

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60024588T Expired - Lifetime DE60024588T2 (de) 1999-01-25 2000-01-25 Substituierte porphyrine und deren therapeutische verwendungen

Country Status (17)

Country Link
US (7) US6544975B1 (enExample)
EP (3) EP1616869B1 (enExample)
JP (1) JP4501128B2 (enExample)
KR (1) KR100753184B1 (enExample)
CN (1) CN1156478C (enExample)
AT (2) ATE552260T1 (enExample)
AU (1) AU779283B2 (enExample)
BR (1) BR0007720B1 (enExample)
CA (1) CA2359116C (enExample)
DE (1) DE60024588T2 (enExample)
DK (2) DK1155019T3 (enExample)
ES (2) ES2254142T3 (enExample)
IL (3) IL144503A0 (enExample)
MX (1) MXPA01007451A (enExample)
NZ (1) NZ513164A (enExample)
WO (1) WO2000043395A1 (enExample)
ZA (1) ZA200106107B (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
EP1045851B1 (en) 1997-11-03 2003-04-23 Duke University Substituted porphyrins
CA2329751C (en) 1998-04-24 2010-10-12 Duke University Substituted porphyrins
EP1616869B1 (en) 1999-01-25 2012-04-04 National Jewish Health Substituted porphyrins and their therapeutic use
FR2806911B1 (fr) * 2000-03-28 2003-01-10 Univ Rene Descartes Utilisation de mimetiques de la sod dans le traitement d'insuffisances hepatocellulaires
US20030069281A1 (en) * 2000-06-14 2003-04-10 Irwin Fridovich Tetrapyrroles
CA2436245C (en) 2001-01-19 2013-04-23 National Jewish Medical And Research Center Medicament for protection in radiotherapy
PT1389617E (pt) * 2001-04-27 2007-04-30 Zenyaku Kogyo Kk Composto heterocíclico e agente antitumoral contendo o mesmo como igrediente activo
WO2002098431A1 (en) * 2001-06-01 2002-12-12 National Jewish Medical And Research Center Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
US20030086916A1 (en) * 2001-10-12 2003-05-08 Goligorsky Michael S. Use of peroxynitrite scavengers or peroxynitrite formation inhibitors that do not diminish nitric oxide synthesis or activity to reverse or prevent premature vascular senescence
EP1513537A4 (en) * 2002-06-07 2006-09-06 Univ Duke Substituted porphyrins
US20040127479A1 (en) * 2002-08-27 2004-07-01 Merck Patent Gmbh Peroxynitrite rearrangement catalysts
EP1581212A4 (en) * 2002-12-06 2008-11-05 Alcon Inc SUPEROXIDE DISMUTASE IMITATIONS FOR THE TREATMENT OF EYE DISORDERS AND DISEASES
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
EP1452175A1 (en) * 2003-02-28 2004-09-01 Medesis Pharma S.A. Manganese based organometallic complexes, pharmaceutical compositions and dietetic products
US20080161255A1 (en) * 2003-05-29 2008-07-03 Michael Brownlee Use of Parp Inhibitors for Prevention and Treatment of Diabetic and Insulin Resistance Complications
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US7699964B2 (en) 2004-02-09 2010-04-20 Abbott Diabetes Care Inc. Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
WO2005077269A1 (en) 2004-02-09 2005-08-25 Duke University Substituted porphyrins
US8165651B2 (en) 2004-02-09 2012-04-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
EA010834B1 (ru) * 2004-03-29 2008-12-30 Инотек Фармасьютикалз Корпорейшн Пиридилзамещённые порфириновые соединения и способы их применения
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
WO2006037050A2 (en) * 2004-09-24 2006-04-06 Metaphore Pharmaceuticals, Inc. Methods for treating congestive heart failure
GB0424294D0 (en) * 2004-11-03 2004-12-01 Elam T Ltd Buffer layer
US7582751B2 (en) * 2005-07-29 2009-09-01 North Carolina State University Methods and intermediates for the synthesis of porphyrins
US7501508B2 (en) * 2005-07-29 2009-03-10 North Caroline State University Methods and intermediates for the synthesis of porphyrins
US7885698B2 (en) * 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
WO2008070579A2 (en) * 2006-12-01 2008-06-12 Loma Linda University Medical Center Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration
US20080289053A1 (en) * 2007-05-15 2008-11-20 The Regents Of The University Of California Methods and systems for identifying modulators of longevity
WO2009004339A2 (en) * 2007-07-03 2009-01-08 Imperial Innovations Limited Compositions and methods relating to manipulation of the myeloid immune compartment during respiratory infection
US8791099B2 (en) * 2007-08-28 2014-07-29 Technion Research And Development Foundation Ltd. Transition metal complexes of corroles for preventing cardiovascular diseases or disorders
US8598150B1 (en) 2008-04-02 2013-12-03 Jonathan R. Brestoff Composition and method for affecting obesity and related conditions
US8987245B2 (en) 2008-04-02 2015-03-24 Jonathan R. Brestoff Parker Composition and method for affecting obesity and related conditions
ES2464728T3 (es) 2008-05-23 2014-06-03 National Jewish Health Compuestos para su uso en el tratamiento de lesiones asociadas con la exposición a una especie química alquilante
US20120065181A1 (en) * 2009-05-26 2012-03-15 Warner David S Method of providing neuroprotection using substituted porphyrins
WO2011028935A2 (en) * 2009-09-02 2011-03-10 The Regents Of The University Of Colorado Methods of treating mitochondrial disorders using metalloporhyrins
HUE029083T2 (en) * 2010-10-06 2017-02-28 Aeolus Sciences Inc Treatment of neurodegenerative diseases with porphyrin
WO2012105483A1 (ja) * 2011-01-31 2012-08-09 国立大学法人宇都宮大学 ポルフィリン型骨格を有する化合物の金属錯体の製造方法
WO2013130150A2 (en) 2011-12-02 2013-09-06 The Regents Of The University Of Colorado, A Body Corporate Metalloporphyrin neurological treatments
CN102775415B (zh) * 2012-07-10 2014-10-22 西北大学 一种卟啉的合成方法
US20140085895A1 (en) * 2012-08-16 2014-03-27 Thomas Frawley LED Bracket Apparatus for High-Output LED Lighting Systems
EP3797798B1 (en) 2013-03-14 2022-09-28 Profusa, Inc. Oxygen sensors
US20160113940A1 (en) 2013-09-03 2016-04-28 Biomimetix J.V., Llc Methods of treating biofilms
CN105899514A (zh) * 2013-11-22 2016-08-24 风神科学公司 卟啉化合物的合成和配制
EP3089666B1 (en) 2013-12-31 2020-08-19 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
US10064871B2 (en) 2014-01-22 2018-09-04 Biomimetix Jv, Llc Methods of treating skin disorders
US10080759B2 (en) 2014-01-22 2018-09-25 Duke University Methods of treating pruritus
AT516549B1 (de) * 2014-11-20 2017-05-15 Wenatex Forschung - Entw - Produktion Gmbh Antimikrobielles Mittel zum biociden Ausrüsten von Polymeren
EP3365349B1 (en) 2015-08-18 2022-06-15 University of Pittsburgh- Of the Commonwealth System of Higher Education Viologen-functionalized porphyrins for reducing biofouling on surfaces
KR20190098211A (ko) * 2016-12-20 2019-08-21 듀크 유니버시티 치환 포르피린 약학적 화합물 및 조성물의 제조 방법
WO2018119204A1 (en) * 2016-12-21 2018-06-28 Profusa, Inc. Polymerizable near-ir dyes
WO2020006248A1 (en) 2018-06-27 2020-01-02 Soya Gamsey Near-ir glucose sensors
CN110028514B (zh) * 2019-05-30 2021-07-02 湖南科技大学 5,10,15,20-四芳基-2,3-咪唑稠合-21-碳叶绿素化合物及制备方法
EP3983486A1 (en) 2019-06-14 2022-04-20 Universidade de Coimbra Small cationic ortho-5,15-di-heteroaryl-porphyrins derivatives and their applications in photoinactivation of microorganisms
US12201649B2 (en) 2021-11-12 2025-01-21 Villanova University Pharmaceutical composition comprising oxidizable biphenol and manganese porphyrin, and method of using the same
CN116284017B (zh) * 2023-03-27 2024-03-22 中国科学院青岛生物能源与过程研究所 一种利用仿酶高效催化氧化制备酰胺化合物的方法

Family Cites Families (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US437221A (en) * 1890-09-30 Circular-saw-smithing machine
US2951799A (en) 1957-11-13 1960-09-06 Monsanto Chemicals Photoxidation processes using heterocyclic photosensitizers
JPS5641611B2 (enExample) * 1973-04-19 1981-09-29
DE3464252D1 (en) 1983-06-03 1987-07-23 Hoffmann La Roche Labelled molecules for fluorescence immunoassays and processes and intermediates for their preparation
US4829984A (en) * 1983-12-15 1989-05-16 Gordon Robert T Method for the improvement of transplantation techniques and for the preservation of tissue
US4963367A (en) 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US5087438A (en) * 1984-07-03 1992-02-11 Gordon Robert T Method for affecting intracellular and extracellular electric and magnetic dipoles
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
GB8429845D0 (en) 1984-11-26 1985-01-03 Efamol Ltd Porphyrins & cancer treatment
US4758422A (en) 1985-01-04 1988-07-19 Salutar Inc. Ferrioxamine paramagnetic contrast agents for MR imaging
US4657902A (en) 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
JPS63500175A (ja) 1985-05-22 1988-01-21 リポソ−ム　テクノロジ−，インコ−ポレイテツド リポソ−ム吸入法および吸入システム
DK402785D0 (da) 1985-09-03 1985-09-03 Syn Tek Ab Fremgangsmaade til fremstilling af et enzym
US5248603A (en) 1985-09-03 1993-09-28 Symbicom Aktiebolag Superoxide dismutase
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4866054A (en) * 1986-05-13 1989-09-12 Chai-Tech Corporation Antioxidant metallo-organic treatment of inflammation
US4746735A (en) 1986-11-21 1988-05-24 The Dow Chemical Company Regiospecific aryl nitration of meso-substituted tetraarylporphyrins
US5162231A (en) 1989-10-25 1992-11-10 Cole Dean A Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung
DE3854872D1 (de) 1987-03-14 1996-02-22 Boehringer Ingelheim Int Humane Mangan-Superoxiddismutase (hMn-SOD)
DE3800973C2 (de) * 1987-03-25 1992-03-19 Degussa Ag, 6000 Frankfurt, De Oxowolfram(v)-porphyrin-komplexe wo(p)x
US5223538A (en) 1987-03-31 1993-06-29 Duke University Superoxide dismutase mimic
US5227405A (en) 1987-03-31 1993-07-13 Duke University Superoxide dismutase mimic
US4892941A (en) 1987-04-17 1990-01-09 Dolphin David H Porphyrins
US4851403A (en) 1987-04-21 1989-07-25 Johnson Matthey, Inc. Radiation sensitizers
US4885114A (en) 1987-04-22 1989-12-05 Barnes Engineering Co. Metallized tetra((meso)-5-methyl-2-thiophene)porphines, platinum (5-bromo octaethylporphine) and optical filters containing same
US5051337A (en) 1987-06-10 1991-09-24 Director-General Of Agency Of Industrial Science And Technology Optical recording material
DE3805697A1 (de) * 1988-02-24 1989-09-07 Bayer Ag Verfahren zur herstellung von p-hydroxy-benzaldehyden
GB8805849D0 (en) 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
US5162519A (en) 1988-03-11 1992-11-10 Efamol Holdings Plc Porphyrins and cancer treatment
DE3809671A1 (de) 1988-03-18 1989-09-28 Schering Ag Porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5284647A (en) 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
FR2632187B1 (fr) * 1988-06-02 1990-09-14 Centre Nat Rech Scient Derives de metalloporphyrines, leur preparation, leur application en therapeutique et leur utilisation pour la preparation de molecules hybrides
US5171680A (en) 1988-06-14 1992-12-15 Chiron Corporation Superoxide dismutase analogs having novel binding properties
JPH0746212B2 (ja) 1988-12-03 1995-05-17 工業技術院長 異方性ｌｂ膜の製造法
JPH02213088A (ja) * 1989-02-13 1990-08-24 Nec Corp 有機薄膜ｅｌ素子及びその製造方法
WO1990010694A1 (fr) 1989-03-06 1990-09-20 Suntory Limited Nouvelle superoxyde dismutase
DK455789D0 (da) 1989-09-15 1989-09-15 Symbicom Ab Polypeptid
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
EP0424033A3 (en) 1989-10-19 1991-07-31 Pola Chemical Industries Inc External skin preparation
US5236915A (en) 1990-05-31 1993-08-17 Health Research, Inc. Meso poly(4-sulfonatophenyl) porphines as MRI image enhancing agents
EP0462836A3 (en) 1990-06-20 1992-08-26 Mitsui Toatsu Chemicals, Inc. Recombinant vector plasmid capable of expressing human manganese superoxide dismutase, and process of producing this enzyme
US5417111A (en) * 1990-08-17 1995-05-23 Analog Devices, Inc. Monolithic chip containing integrated circuitry and suspended microstructure
US5217966A (en) 1990-09-13 1993-06-08 The Regents Of The University Of California Synthetic drug molecules that mimic metalloenzymes
US5202317A (en) 1990-09-13 1993-04-13 The Regents Of The University Of California Synthetic drug molecules that mimic metalloenzymes
WO1992007935A1 (en) 1990-11-01 1992-05-14 The Scripps Research Institute Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions
WO1992008482A1 (en) 1990-11-14 1992-05-29 Uab Research Foundation Compositions for reducing oxidative injury
US5192757A (en) * 1990-12-20 1993-03-09 Glaxo Inc. Cobalt porphyrins
DE69212850T2 (de) * 1991-01-15 1997-03-06 Alcon Lab Inc Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen
GB9103991D0 (en) 1991-02-26 1991-04-10 Nat Res Dev Molecular electronic devices
US5212162A (en) * 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
FR2676738B1 (fr) 1991-05-22 1995-05-05 Ir2M Nouveau derive organique de metal de transition a structure porphyrinique, composition therapeutique le contenant, en particulier a activite hypoglycemiante.
CA2072934C (en) * 1991-07-19 2007-08-28 Karl William Aston Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
DE69224839T2 (de) 1991-07-19 1998-10-08 Monsanto Co Mangan-Komplexe mit Stickstoff enthaltenden makrozyklischen Liganden, wirksam als Superoxiddismutasekatalysatoren.
US5262532A (en) 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
US5212300A (en) 1991-09-12 1993-05-18 Sun Company, Inc. (R&M) Cyano- and polycyanometallo-porphyrins as catalysts for alkane oxidation
US5976551A (en) * 1991-11-15 1999-11-02 Institut Pasteur And Institut Nationale De La Sante Et De La Recherche Medicale Altered major histocompatibility complex (MHC) determinant and method of using the determinant
US5599924A (en) 1992-08-14 1997-02-04 Trustees Of The University Of Pennsylvania Electron-deficient porphyrins and processes and intermediates for preparing same
US5371199B1 (en) 1992-08-14 1995-12-26 Univ Pennsylvania Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor
US5493017A (en) 1992-08-14 1996-02-20 The Trustees Of The University Of Pennsylvania Ring-metalated porphyrins
ES2157221T3 (es) 1992-09-03 2001-08-16 Univ California Composiciones metaloporfirinicas.
US5403834A (en) * 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5834509A (en) * 1992-12-07 1998-11-10 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5696109A (en) 1992-12-07 1997-12-09 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US6204259B1 (en) * 1993-01-14 2001-03-20 Monsanto Company Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
DE4305523A1 (de) 1993-02-17 1994-08-18 Diagnostikforschung Inst Meso-Tetraphenylporphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US5428037A (en) 1993-04-09 1995-06-27 Syntex Pharmaceuticals, Ltd. Heterocyclic derivatives in the treatment of Ischaemia and related diseases
JP3273082B2 (ja) 1993-06-18 2002-04-08 三和電気工業株式会社 光コネクタ用スリ−ブホルダ
JPH0743337A (ja) * 1993-07-30 1995-02-14 Toppan Printing Co Ltd マンガンポルフィリン錯体を感応物質とする陰イオン選択性電極
US6417182B1 (en) * 1993-08-25 2002-07-09 Anormed Inc. Pharmaceutical compositions comprising metal complexes
US5747026A (en) 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5994339A (en) 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
US5488145A (en) 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
US5608054A (en) 1993-12-29 1997-03-04 Sun Company, Inc. (R&M) Porphyrins and metal complexes thereof having haloalkyl side chains
US5405369A (en) * 1994-01-25 1995-04-11 Medical College Of Ohio Photochemical ablation of gastro-intestinal tissue for augmentation of an organ
US5604199A (en) * 1994-03-29 1997-02-18 The Nemours Foundation Method of treating fibrosis in skeletal muscle tissue
CZ323496A3 (en) * 1994-05-13 1997-10-15 Monsanto Co Pharmaceutical composition containing a catalyst of peroxy nitrite decomposition
US6245758B1 (en) * 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
US5563132A (en) * 1994-06-21 1996-10-08 Bodaness; Richard S. Two-step cancer treatment method
AU3758695A (en) 1994-09-20 1996-04-09 Duke University Oxidoreductase activity of manganic porphyrins
CA2132690A1 (en) 1994-09-22 1996-03-23 Dean Willis Control and modulation of inflammatory response in humans in need of such control and modulation
US6013241A (en) * 1995-01-23 2000-01-11 Schering Aktiengesellschaft Use of porphyrin-complex or expanded porphyrin-complex compounds as an infarction localization diagnosticum
EP0831891B1 (en) * 1995-06-07 2005-10-19 Duke University Oxidant scavengers
CA2229781A1 (en) 1995-08-17 1997-02-27 Monsanto Company Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands
US5976498A (en) * 1995-08-17 1999-11-02 Neumann; William L. Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
CA2229799A1 (en) 1995-08-17 1997-02-27 Monsanto Company Bioconjugates of manganese complexes and their application as catalysts
US5648523A (en) * 1995-10-26 1997-07-15 Chiang Long Y Fullerene derivatives as free-radical scavengers
US5948771A (en) * 1996-01-31 1999-09-07 The Trustees Of Columbia University In The City Of New York Method for treating heart failure using tetrapyrroles and metallotetrapyrroles
JP2000507929A (ja) 1996-03-13 2000-06-27 モンサント カンパニー ジスムタチンスーパーオキシドの触媒として有効な窒素含有大環状化合物配位子を持つ鉄錯体
WO1997033877A1 (en) 1996-03-13 1997-09-18 Monsanto Company Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
JPH1062350A (ja) * 1996-08-14 1998-03-06 Ebara Corp ガス反応性色素を用いたガス検知方法及びガス検知装置
US5756492A (en) * 1996-09-09 1998-05-26 Sangstat Medical Corporation Graft survival prolongation with porphyrins
AU6650198A (en) 1997-02-05 1998-08-25 Board Of Regents, The University Of Texas System Porphyrin compounds as telomerase inhibitors
US6214817B1 (en) * 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
US6180620B1 (en) 1997-06-20 2001-01-30 G.D. Searle & Co. Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
GB9716446D0 (en) 1997-08-05 1997-10-08 Agrevo Uk Ltd Fungicides
JP3564962B2 (ja) * 1997-08-26 2004-09-15 松下電器産業株式会社 光記録媒体及びその光記録再生方法
ATE292112T1 (de) 1997-08-26 2005-04-15 Kumiai Chemical Industry Co Biarylalkylencarbaminsäurederivate als bakteriozide in landwirtschaft und gartenbau
EP1045851B1 (en) * 1997-11-03 2003-04-23 Duke University Substituted porphyrins
CA2329751C (en) * 1998-04-24 2010-10-12 Duke University Substituted porphyrins
CA2337756A1 (en) 1998-07-23 2000-02-03 Otto F. Schall Libraries of polyhydroxamates and their analogs
WO2000023568A2 (en) 1998-10-06 2000-04-27 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells
EP1616869B1 (en) * 1999-01-25 2012-04-04 National Jewish Health Substituted porphyrins and their therapeutic use
DE60037768T2 (de) 1999-05-27 2009-01-15 Pharmacia Corp.(N.D.Ges.D.Staates Delaware) Biomaterialien, modifiziert mit Superoxid-Dismutase Imitatoren
US6448239B1 (en) 1999-06-03 2002-09-10 Trustees Of Princeton University Peroxynitrite decomposition catalysts and methods of use thereof
US6608050B2 (en) * 1999-07-20 2003-08-19 Pharmacia & Upjohn Company Lyophilizate of lipid complex of water insoluble porphyrins
AU1087401A (en) 1999-10-13 2001-04-23 Uab Research Foundation Metalloporphyrin treatment of neurologic disease
AU771600B2 (en) * 1999-11-30 2004-03-25 Photochemical Co., Ltd. Nitroimidazole-supporting porphyrin complex
JP3383839B2 (ja) * 2000-03-13 2003-03-10 奈良先端科学技術大学院大学長 新規なメルカプト置換イミダゾリルポルフィリン金属錯体単量体及びこれを繰り返し単位として有する重合体並びにこれらの製造方法
US6624187B1 (en) * 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
EP1320532A1 (en) 2000-06-14 2003-06-25 Duke University Tetrapyrroles
US6403788B1 (en) * 2000-07-11 2002-06-11 Eukarion, Inc. Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
US6573258B2 (en) * 2000-09-27 2003-06-03 Frontier Scientific, Inc. Photodynamic porphyrin antimicrobial agents
CA2436245C (en) * 2001-01-19 2013-04-23 National Jewish Medical And Research Center Medicament for protection in radiotherapy
WO2002078670A1 (en) 2001-03-02 2002-10-10 Neuron Therapeutics, Inc. Neuroprotectants formulations and methods
AU2002344234B2 (en) 2001-05-31 2007-11-08 Miravant Pharmaceuticals, Inc. Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
US6566517B2 (en) * 2001-06-06 2003-05-20 Brookhaven Science Associates, Llc Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy
DE10240343A1 (de) 2002-08-27 2004-03-11 Schering Ag Peroxynitrit-Umlagerungskatalysatoren
WO2005077269A1 (en) 2004-02-09 2005-08-25 Duke University Substituted porphyrins
JP2008538586A (ja) 2005-04-21 2008-10-30 グレン エー． ゴールドスタイン， 酸化ストレスに関連する疾患および病気の処置のためのｎ−アセチルシステインアミド（ｎａｃアミド）
WO2011028935A2 (en) 2009-09-02 2011-03-10 The Regents Of The University Of Colorado Methods of treating mitochondrial disorders using metalloporhyrins

Also Published As

Publication number Publication date
CN1355802A (zh) 2002-06-26
IL144503A (en) 2007-10-31
WO2000043395A8 (en) 2000-08-31
US9289434B2 (en) 2016-03-22
KR100753184B1 (ko) 2007-08-30
US6544975B1 (en) 2003-04-08
US20150231150A1 (en) 2015-08-20
DK1616869T3 (da) 2012-05-07
BR0007720B1 (pt) 2014-04-08
ATE552260T1 (de) 2012-04-15
US20110065679A1 (en) 2011-03-17
EP1155019A4 (en) 2002-07-03
WO2000043395A1 (en) 2000-07-27
US8546562B2 (en) 2013-10-01
HK1047744A1 (en) 2003-03-07
ES2254142T3 (es) 2006-06-16
KR20010108130A (ko) 2001-12-07
IL183953A0 (en) 2007-10-31
DE60024588D1 (de) 2006-01-12
AU779283B2 (en) 2005-01-13
EP1155019A1 (en) 2001-11-21
BR0007720A (pt) 2001-10-30
EP1616869B1 (en) 2012-04-04
US20070197496A1 (en) 2007-08-23
AU779283C (en) 2000-08-07
ATE312103T1 (de) 2005-12-15
US20120214780A1 (en) 2012-08-23
DK1155019T3 (da) 2006-04-18
CA2359116C (en) 2009-03-17
IL144503A0 (en) 2002-05-23
CN1156478C (zh) 2004-07-07
US20040023941A1 (en) 2004-02-05
US8217026B2 (en) 2012-07-10
AU2740700A (en) 2000-08-07
NZ513164A (en) 2006-03-31
EP1155019B1 (en) 2005-12-07
MXPA01007451A (es) 2004-03-10
US20140011794A1 (en) 2014-01-09
JP2002535332A (ja) 2002-10-22
US8946202B2 (en) 2015-02-03
CA2359116A1 (en) 2000-07-27
IL183953A (en) 2010-12-30
US7189707B2 (en) 2007-03-13
HK1083626A1 (en) 2006-07-07
EP2295435A1 (en) 2011-03-16
JP4501128B2 (ja) 2010-07-14
EP1616869A1 (en) 2006-01-18
ES2385486T3 (es) 2012-07-25
US7820644B2 (en) 2010-10-26
ZA200106107B (en) 2002-12-24

Similar Documents

Publication Publication Date Title
DE60024588T2 (de) Substituierte porphyrine und deren therapeutische verwendungen
DE69928655T2 (de) Substituierte porphyrine
DE69813898T2 (de) Substituierte porphyrinen
DE60319406T2 (de) Meso-substituierte porphyrine
DE60108507T2 (de) Nicht genotoxische metalloporphyrine als synthetische katalytische fänger von reaktiven sauerstoffspezies
DE60205085T2 (de) Metallphthalocyanin-analoge enthaltende antibakterielle Zusammensetzungen
CH615410A5 (en) Process for the preparation of novel alpha-ethylbenzhydrol derivatives
EP2072584B1 (de) Phthalocyanin-Farbstoffe, ihre Herstellung und Verwendung
DE60100704T2 (de) Porphyrine und verwandte verbindungen
HK1083626B (en) Substituted porphyrins and their therapeutic use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition